PreciDIAB ambition is to revolutionize the way diabetes is managed within 10-yr period. This requires radical changes in the way health professionals are educated and trained. It implies a multi-dimension teaching and training program that improves knowledge and motivation of each actor of the chain without weak link. We will build the first diabetes international graduate school with a high caliber MD/PhD program, teaching cutting-edge science in metabolic diseases, and best operating practice between academic and private research and clinical practice, to foster the transition from discoveries to innovation. In addition, we will establish with our partners an annual international summer school for entrepreneurship in diabetes (ISSED) to facilitate innovations in diabetes.
This program should generate the next-generation diabetes research leaders in Europe for academia, industry and biotech. It is supported by our pool of world-renowned scientists from LABEX EGID and associated French partners, and from our established network of excellence including our associated international laboratory with Lausanne University (CNRS LEA), Leuven and Louvain Universities (main partner of Lille I-SITE) and Montreal CHUM.